U.N. Millenium Project in sync with Millenia Hope
Delaware, USA, October 11, 2005 – Millenia Hope, Inc. (OTCBB: MLHP) is an international company that fights disease through treatment, prevention and via environmental renewal and dissemination of crucial information to people around the globe. Millenia Hope is proud to announce the commencement of its “Hope Village” projects, a conceptualization of Millenia, over the past several years, now being brought to actualization.
This project, originally conceived by Millenia, perfectly suits the objectives of the UN’s Millenium Development Goals, the recently held G-8 Summit and the World Summit on Sustainable Development. In order to implement an effective partnership, our program is designed to strengthen, enlarge and support local governance in the fight against malaria. We will also promote private-sector initiatives, maximize domestic responsibility and partner with international and local NGOs in order to reach afflicted populations.
As stated on the U.N. Millenium Project’s website, “The underlying principle for each Millennium Village is that community empowerment, participation and leadership are key to designing and implementing the solutions.”
Each pre-selected African Village will implement a Home Based Treatment (HBT) anti-malarial program, since 80% of all deaths occur at home. HBT specifically targets women and children, as they are the segment of the population at the greatest risk. The programs will include: education geared towards the village women, the primary home and health care givers, effective anti-malarial treatments for the entire village consisting of MMH™ Malarex/MMH™18, a new anti-malarial agent with no parasite resistance, attention to the environmental factors inherent in the spread of malaria i.e. stagnant water etc. and the promotion of co-operation between private individuals and public sector institutions in this initiative.
Millenia Hope Inc. and its private foundation, Millenia Hope Foundation (UK), are already in the midst of negotiating the implementation of Millenia’s initial “Hope Villages” in Africa, in accordance with Millenia’s visionary idea.
Leonard Stella, Chairman and CEO of Millenia Hope and the Founder and CEO of the Millenia Hope Foundation (UK), proclaimed, “To see one of our pivotal goal projects embraced by the U.N. and on the road to fruition is extremely gratifying for Millenia Hope”. Mr. Stella and Mr. Cyril Boynes Jr., Director of International Affairs of The Congress of Racial Equality (CORE), stated that, “we are in complete agreement with the process of self-actualization of the African people to determine their own destiny.” Mr. Stella added, “this is the reason why Millenia Hope acquired its homologations in Africa first and only now is doing so in North America. Malaria is a problem that a ravage, primarily, third world developing countries and part of the solution is in their hands”.
There are 600 million malaria-infected individuals globally; 3 million die annually, of which 1 million are children under 5 years of age. In many regions, 70% or more of malaria strains are resistant to existing medications and the WHO is no longer funding products like chloroquine to which malaria is resistant. MMH Malarex™ cures malaria in those regions where resistant strains are prevalent. MMH Malarex™ has cured nearly 1,000 malaria suffers in its various trials over the last 5 years. We are saving lives right now!
About Millenia Hope:
Millenia Hope develops innovative treatments and quality products that will increase the quality of life, provide tools in the fight against diseases, and promote healthier lives. Our team is committed to research and development to deliver on global medical needs and to bring hope through healthcare solutions.
Certain statements made in this release may contain language describing the plans, goals, strategies, intentions, forecasts and expectations of Millenia Hope that may be referred to as “forward – looking statements.” Several important factors could cause actual results to differ materially from those in such forward – looking statements, and Millenia Hope could encounter unanticipated obstacles and delays in developing products, services and markets.
For more information:
Please contact: Mr. Leonard Stella CEO
Tel: 514-846-5757 or 514-288-8822
Last updated on: 27/08/2010
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.